ÂÜÀòÂÒÂ×

Chris Kelberman is an experienced finance executive currently serving as Chief Financial Officer at Sanguine since 2022. Prior to this role, Chris held various positions at MassBiologics from 2017 to 2022, including Executive Director of Finance and Controller. Chris's career includes significant roles at inVentiv Health, where responsibilities spanned from VP of Business Intelligence & Analytics to CFO of the Patient Outcomes Division. Earlier positions include Director of Finance at PAREXEL and AGAR, as well as VP Finance & Administration at Roper Industries. Chris began a career in finance with Cytyc as Director of Financial Operations, Planning & Analysis. Chris holds a BS and MBA in Finance from the Questrom School of Business at Boston University.